# LibTV's Three Flagship Models Available with Unlimited Zero-Point Usage for Up to 30 Days

- Category: Flash (快讯)
- Published: 2026-10-29T12:00:00.000Z
- Source date: 2026-10-29
- HTML: https://www.88z.ai/en/news/flash-20261029-474d031181e2f958
- Markdown: https://www.88z.ai/en/news/flash-20261029-474d031181e2f958.md
- Other language: https://www.88z.ai/news/flash-20261029-474d031181e2f958.md

LibTV has launched a Double 11 promotion for AI video creation, offering unlimited zero-point usage of its three flagship models, Wan 3, Kling 4.0, and Minimax H3, for up to 30 days. Seedance 2.5 720P is priced as low as 0.17 yuan per second. Annual members can save 1300 yuan with red packets, receive an additional three months of membership and over 170,000 points, while the Supreme 92K annual package sees a significant price reduction. The creator growth program has also been upgraded, with in

## At a glance

- Wan 3, Kling 4.0, and Minimax H3 models offer up to 30 days of unlimited zero-point usage
- Supreme 92K annual package reduced to 16,999 yuan, with single-work incentives capped at 100,000 yuan

## The update

Leveraging the Double 11 shopping festival, LibTV has introduced its lowest prices of the year for AI video creation. Users can enjoy unlimited zero-point access to three flagship video models, Wan 3, Kling 4.0, and Minimax H3, for up to 30 days. Additionally, the cost for Seedance 2.5 720P generation has dropped to 0.17 yuan per second. Annual members benefit from a 1300 yuan discount via stacked red packets, along with a bonus of three extra months of membership and over 170,000 points. The price for the Supreme 92K annual package has been significantly adjusted from 40,999 yuan to 16,999 yuan. Furthermore, LibTV has upgraded its creator growth program, raising the cap for single-work incentives to 100,000 yuan to better support high-quality content creation.

## Sources

- [LibTV](https://mp.weixin.qq.com/s/NVwl-gmXo1bbYIyK7n5JLg) (2026-10-29)

This article is an AI-assisted synthesis by 88Z AI based on the public sources below. Product claims and availability are attributed to their publishers. It does not represent independent testing or first-hand reporting.